Cargando…

Asthma heterogeneity and severity

Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology. The incident factors, pathog...

Descripción completa

Detalles Bibliográficos
Autores principales: Carr, Tara F., Bleecker, Eugene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129643/
https://www.ncbi.nlm.nih.gov/pubmed/27980705
http://dx.doi.org/10.1186/s40413-016-0131-2
_version_ 1782470625610170368
author Carr, Tara F.
Bleecker, Eugene
author_facet Carr, Tara F.
Bleecker, Eugene
author_sort Carr, Tara F.
collection PubMed
description Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology. The incident factors, pathogenesis, prognosis, and treatment of asthma remain incompletely understood. Utilizing measurable characteristics of asthmatic patients, including demographic, physiologic, and biologic markers, can however identify meaningful phenotypic categories in asthma. Identification of these phenotypes may help improve precision therapeutics targeted toward an individual’s’ disease, and may identify strategies for preventing progression of disease severity.
format Online
Article
Text
id pubmed-5129643
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-51296432016-12-15 Asthma heterogeneity and severity Carr, Tara F. Bleecker, Eugene World Allergy Organ J Review Asthma is a common, chronic inflammatory airways disease characterized by a clinical syndrome of bronchial hyperresponsiveness, inflammation, and reversible airflow obstruction. Individuals with asthma can vary widely in clinical presentation, severity, and pathobiology. The incident factors, pathogenesis, prognosis, and treatment of asthma remain incompletely understood. Utilizing measurable characteristics of asthmatic patients, including demographic, physiologic, and biologic markers, can however identify meaningful phenotypic categories in asthma. Identification of these phenotypes may help improve precision therapeutics targeted toward an individual’s’ disease, and may identify strategies for preventing progression of disease severity. BioMed Central 2016-11-29 /pmc/articles/PMC5129643/ /pubmed/27980705 http://dx.doi.org/10.1186/s40413-016-0131-2 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Review
Carr, Tara F.
Bleecker, Eugene
Asthma heterogeneity and severity
title Asthma heterogeneity and severity
title_full Asthma heterogeneity and severity
title_fullStr Asthma heterogeneity and severity
title_full_unstemmed Asthma heterogeneity and severity
title_short Asthma heterogeneity and severity
title_sort asthma heterogeneity and severity
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129643/
https://www.ncbi.nlm.nih.gov/pubmed/27980705
http://dx.doi.org/10.1186/s40413-016-0131-2
work_keys_str_mv AT carrtaraf asthmaheterogeneityandseverity
AT bleeckereugene asthmaheterogeneityandseverity